Although half of all patients with heart failure ( HF ) have a normal or near-normal ejection fraction and their prognosis differs little from that of patients with a reduced ejection fraction , the pathophysiology of HF with preserved ejection fraction ( HF-PEF ) is still poorly understood , and its management poorly supported by clinical trials .